Regeneron Pharmaceuticals, Inc.
ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS
Last updated:
Abstract:
The present invention includes an antibody or antigen-binding fragment thereof that binds specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., influenza virus infections).
Status:
Application
Type:
Utility
Filling date:
20 Jan 2021
Issue date:
29 Jul 2021